PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE TREATMENT IN CHILDREN

被引：29

作者：

BRATLID, D ^{[1
]}

MOE, PJ ^{[1
]}

机构：

[1] UNIV TROMSO HOSP,INST CLIN MED,DEPT PEDIAT,TROMSO,NORWAY

来源：

关键词：

D O I：

10.1007/BF00607446

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：143 / 147

页数：5

共 15 条

[1] DISPLACEMENT OF ALBUMIN-BOUND ANTIMICROBIAL AGENTS BY BILIRUBIN
BRATLID, D
BERGAN, T
[J]. PHARMACOLOGY, 1976, 14 (05) : 464 - 472
[2] Dahl S G, 1974, Tidsskr Nor Laegeforen, V94, P1208
[3] DJERASSI I, 1972, CANCER, V30, P22, DOI 10.1002/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO
[4] 2-B
[5] FREI E, 1975, NEW ENGL J MED, V292, P107
[6] METHOTREXATE TOXICITY - CORRELATION WITH DURATION OF ADMINISTRATION, PLASMA LEVELS, DOSE AND EXCRETION PATTERN
GOLDIE, JH
HARRAP, KR
PRICE, LA
[J]. EUROPEAN JOURNAL OF CANCER, 1972, 8 (04) : 409 - &
[7] HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572
[8] ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA
JAFFE, N
FREI, E
TRAGGIS, D
BISHOP, Y
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 994 - 997
[9] PLASMA-LEVELS OF METHOTREXATE IN CANCER-PATIENTS AS STUDIED BY AN IMPROVED SPECTROPHOTOFLUOROMETRIC METHOD
KINKADE, JM
VOGLER, WR
DAYTON, PG
[J]. BIOCHEMICAL MEDICINE, 1974, 10 (04): : 337 - 350
[10] LEWITT M, 1973, CANCER RES, V32, P1729